Related Experiment Videos
Seizure associated with olanzapine.
J W Lee1, M L Crismon, P G Dorson
1Psychiatric Pharmacy Practice, College of Pharmacy, The University of Texas at Austin, and Austin State Hospital, USA. pmyjwl@ttuhsc.edu
The Annals of Pharmacotherapy
|June 16, 1999
Summary
This case report suggests olanzapine may be linked to seizures in susceptible patients, highlighting the need for careful monitoring. Postmarketing surveillance is crucial for identifying potential risks of new antipsychotic medications.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Psychiatry
Background:
- Antipsychotic medications are widely used for treating various psychiatric disorders.
- Olanzapine is an atypical antipsychotic with a generally favorable safety profile.
- Seizure risk is a known, albeit uncommon, concern with some antipsychotic agents.
Observation:
- A patient with a history of generalized seizure disorder experienced seizure activity after initiating olanzapine.
- The patient had multiple confounding factors, including other medical and psychiatric conditions and concurrent medications.
- Discontinuation of olanzapine and reintroduction of haloperidol, along with phenytoin, resolved the seizure activity.
Findings:
- Causality is complex due to multiple contributing factors.
- The potential for olanzapine to precipitate seizures in this patient was considered possible.
- While premarketing data suggested minimal seizure liability, this case underscores the importance of postmarketing surveillance.
Implications:
- This case highlights the need for vigilance regarding seizure risk with olanzapine, particularly in patients with pre-existing seizure disorders.
- It emphasizes the critical role of postmarketing surveillance in detecting rare or previously unrecognized adverse drug reactions.
- Clinicians should carefully consider individual patient factors and potential drug interactions when prescribing antipsychotics like olanzapine.